The U.S. stock market is on an extended bull run that started in October 2022, pushing up valuations to unsustainable levels ...

Alibaba’s revenue and profit in December quarter topped estimates, helping the Hang Seng Index log its longest winning run ...

We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will summarize the bulls’ thesis on DERM. Journey Medical Corporation (DERM)’s ...

Gold has momentarily paused just below $3,000, catching its breath while building momentum for its next move. With energy ...

Wednesday's minutes from the Fed's January meeting revealed most central bank officials supported holding policy at ...

Investors are weighing Trump's latest tariff salvo and waiting for Fed minutes for insight into future policy.

Separately, Palantir filed notice with the U.S. Securities and Exchange Commission on Tuesday that CEO Alex Karp adopted a ...

The bull run has just a few years left, and investors want to arm themselves with stocks that have potential, like Rivian, ...

It’s no mystery why some investors feel a bit nervous as the bull run goes into a new year. Extended valuations and growing ...

Public equities performed strongly in 2024, driven primarily by U.S. large-cap growth assets. That created some imbalances in ...

Market observers note that Remittix’s approach is more than just another DeFi gimmick. The platform is tapping into the $183 ...

In our analysis, these 12 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...